Skip to main content
. 2018 Feb 10;55(4):254–260. doi: 10.1136/jmedgenet-2017-104957

Figure 2.

Figure 2

Risk stratification for AIP mutations, classified as low risk (<5%), moderate risk (5%–19%) or high risk (≥20%). Red: risk of AIP mutation ≥20%; orange: risk of AIP mutation between 5% and 19%; green: risk of AIP mutation <5%. GH, growth hormone; macro, macroadenoma; micro, microadenoma; simplex, patients with no known family history.